Theme editorial| Volume 18, ISSUE 4, P603-612, December 1997

When less is more: Cost-containment in transfusion medicine

      This paper is only available as a PDF. To read, Please Download here.


      The drive to contain the rising cost of medical care provides numerous challenges to blood bankers. Not the least of these is the opportunity to improve quality of care while reducing the cost thereof. This paper explores various cost-reduction strategies, focusing primarily on those applicable to small and medium-sized transfusion services, and demonstrates methods by which they can be implemented to yield improved patient care.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Transfusion and Apheresis Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Rosen NR
        • Bates LH
        • Herod G
        Transfusion therapy: improved patient care and resource utilization.
        Transfusion. 1993; 33: 341-347
        • Heddle NM
        • O'Hoski P
        • Singer J
        A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing.
        Br J Haematol. 1992; 81: 579-584
        • Shulman IA
        • Nelson JM
        • Saxena S
        Experience with the routine use of an abbreviated crossmatch.
        Am J Clin Pathol. 1984; 82: 178-181
        • Pinkerton PH
        • Coovadia AS
        • Goldstein J
        Frequency of delayed hemolytic transfusion reactions following antibody screening and immediate-spin cross-matching.
        Transfusion. 1992; 32: 814-817
        • Meyer EA
        • Shulman IA
        The sensitivity and specificity of the immediate-spin crossmatch.
        Transfusion. 1989; 29: 99-102
        • Shulman IA
        • Meyer EA
        • Lam H-T
        • Nelson JM
        Additional limitations of the immediate spin crossmatch to detect ABO incompatibility.
        Am J Clin Pathol. 1987; 87: 677
        • Beck ML
        • Tilzer LL
        Red cell compatibility testing: A perspective for the future.
        Transfus Med Rev. 1996; 10: 118-130
        • Shulman IA
        • Nelson JM
        • Kent DR
        Experience with a cost-effective cross-match protocol.
        J Am Med Assoc. 1985; 254: 93-95
        • Judd WJ
        Are there better ways than the crossmatch to demonstrate ABO incompatibility?.
        Transfusion. 1991; 31: 192-194
        • Standards Committee of the American Association of Blood Banks
        Standards for Blood Banks and Transfusion Services.
        17th edn. American Association of Blood Banks, Bethesda, MD1996
        • Shulman IA
        • Kent D
        Safety in transfusion practice: Is it safe to eliminate the major crossmatch for selected patients?.
        Arch Pathol Lab Med. 1989; 113: 270-272
        • Riccardi D
        • Giovanetti AM
        • Parravicini A
        Risk of ABO and non-ABO incompatibility using type and screen and electronic crossmatch.
        Transfusion. 1991; 31 (Abstr, Suppl): 60S
        • Judd WJ
        • Oberman HJ
        • Steiner EA
        • Baure RC
        The evaluation of a positive direct antiglobulin test in pretransfusion testing.
        Transfusion. 1980; 20: 17-23
        • Judd WJ
        • Barnes BA
        • Steiner EA
        The evaluation of a positive direct antiglobulin test (autocontrol) in pretransfusion testing revisited.
        Transfusion. 1986; 26: 220-224
        • Stec N
        • Shirey RS
        • Smith B
        • Kickler TS
        • Ness PM
        The efficacy of performing red cell elution studies in pretransfusion testing of patients with positive direct antiglobulin tests.
        Transfusion. 1986; 26: 225-226
        • Aubuchon JP
        Blood transfusion options: improving outcomes and reducing costs.
        Arch Pathol Lab Med. 1997; 121: 40-47
        • Ransom SB
        • McNeeley SG
        • Hosseini RB
        Cost-effectiveness of routine blood type and screen testing before elective laparoscopy.
        Obstet Gynecol. 1995; 86: 346-348
        • Cousins LM
        • Teplick FB
        • Poeltler DM
        Pre-cesarean blood bank orders: A safe and less expensive approach.
        Obstet Gynecol. 1996; 87: 912-916
        • Galea G
        • Urbaniak SJ
        Blood transfusion practice in gynaecology and obstetrics: Retrospective audit.
        Vox Sang. 1994; 67: 323-325
        • Brandis K
        • Richards B
        • Ghent A
        • Weinstein S
        A strategy to reduce inappropriate red blood cell transfusion.
        Med J Aust. 1994; 160: 721-722
        • Morrison JC
        • Sumrall DD
        • Chevalier SP
        The effect of provider education on blood utilization practices.
        Am J Obstet Gynecol. 1993; 169: 1240-1245
        • Silver H
        • Tahhan HR
        • Anderson J
        • Lachman M
        A non computer-dependent prospective review of blood and blood component utilization.
        Transfusion. 1992; 32: 260-265
        • Schrieber GB
        • Busch MP
        • Kleinman SH
        • Korelitz JJ
        • for the Retrovirus Epidemiology Donor Study
        The risk of transfusion-transmitted viral infections.
        N Engl J Med. 1996; 334: 1685-1690
        • Halsey PB
        • Lave JR
        • Kapoor WN
        The necessary and unnecessary transfusion: a critical review of reported appropriateness rates and criteria for red cell transfusions.
        Transfusion. 1994; 34: 110-115
        • Saxena S
        • Weiner JM
        • Rabinowitz A
        Transfusion practice in medical patients.
        Arch Intern Med. 1993; 153: 2375-2380
        • Goodnough LT
        • Soegiarso RW
        • Birkmeyer JD
        • Welch HG
        Economic impact of inappropriate blood transfusions in coronary artery bypass surgery.
        Am J Med. 1993; 94: 509-514
        • Forbes JM
        • Anderson MD
        • Anderson GF
        Blood transfusion costs: A multicenter study.
        Transfusion. 1991; 31: 318-323
        • Lubarsky DA
        • Hahn C
        • Bennett DH
        The hospital cost (fiscal year 1991/1992) of a simple perioperative allogeneic red blood cell transfusion during elective surgery at Duke University.
        Anesth Analg. 1994; 79: 629-637
        • Soumerai SB
        • Salem-Schatz S
        • Avorn J
        • Casteris CS
        • Ross-Degnan D
        • Popovsky MA
        A controlled trial of educational outreach to improve blood transfusion practice.
        J Am Med Assoc. 1993; 270: 961-966
        • Lam H-T
        • Schweitzer SO
        • Petz L
        Are retrospective peer-review transfusion monitoring systems effective in reducing red blood cell utilization?.
        Arch Pathol Lab Med. 1996; 120: 810-816
        • Gmur J
        • Burger J
        • Schanz U
        Safety of stringent prophylactic platelet transfusion policy for patients with acute leukemia.
        Lancet. 1991; 338: 1223-1226
        • Wandt H
        • Frank M
        • Schneider C
        • Ehninger G
        • Link H
        The 10,000/iL trigger compared to 20,000/μL for prophylactic platelet transfusion in AML: A prospective comparative multicenter study [abstract].
        Blood. 1996; 88: 443a
        • Aubuchon JP
        Platelet transfusion therapy.
        Clin Lab Med. 1996; 16: 797-816
        • Strauss RG
        Clinical perspectives of platelet transfusion: Defining the optimal dose.
        J Clin Apheresis. 1995; 10: 124-127
        • Kelley DL
        • Fegan R
        • Ng AT
        Four pooled platelet concentrates (PC) have therapeutic efficacy (TE) of apheresis platelets after optimization by continuous quality improvement [Abstract Suppl].
        Transfusion. 1995; 35: 8S
        • Gmur J
        • von Felten A
        • Osterwalder B
        Delayed alloimmunization using random single donor platelet transfusions: A prospective study in thrombocytopenic patients with acute leukemia.
        Blood. 1983; 62: 473-479
        • Heddle NM
        • Blajchman MA
        The leukodepletion of cellular blood products in the prevention of HLA-alloimmunization and refractoriness to allogeneic platelet transfusions.
        Blood. 1995; 85: 603-606
        • Heddle NM
        The efficacy of leukodepletion to improve platelet transfusion response: A critical appraisal of clinical studies.
        Transfus Med Rev. 1994; 8: 15-28
        • Schiffer CA
        Prevention of alloimmunization against platelets.
        Blood. 1991; 77: 1-4
        • Williamson LM
        • Wimperis JZ
        • Williamson P
        • et al.
        • for the Alloimmunisation Study Group
        Bedside filtration of blood products in the prevention of HLA alloimmunization-A prospective randomized study.
        Blood. 1994; 83: 3028-3035
        • Sintnicolaas M
        • van Marwijk Kooij M
        • van Prooijen BA
        Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: A randomized prospective study.
        Blood. 1995; 85: 824-828
        • Slichter S
        Report on results of Trial to Reduce Alloimmunization to Platelets.
        in: Annual Meeting, American Association of Blood Banks, Orlando, FLOctober 1996
        • Perkins HA
        Is white cell reduction cost-effective?.
        Transfusion. 1993; 33: 626-628
        • Bowden RA
        • Slichter SJ
        • Sayers M
        A comparison of filtered leukocytereduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant.
        Blood. 1995; 86: 3598-3603
        • Balducci L
        • Benson K
        • Lyman GH
        Cost-effectiveness of white cell-reduction filters in treatment of adult acute myelogenous leukemia.
        Transfusion. 1993; 33: 665-670
        • Blumberg N
        • Heal JM
        • Kirkley SA
        Leukocyte-depleted-ABO-identical blood components in the treatment of hematologic malignancies: A cost analysis.
        Am J Hematol. 1995; 48: 108-115
        • Oberman HA
        Controversies in transfusion medicine: Should a febrile transfusion response occasion the return of the blood component to the blood bank?.
        Con Transfusion. 1994; 34: 353-355
        • Standards Committee of the American Association of Blood Banks
        Special insert: Proposed changes to standards for blood banks and transfusion services.
        News Briefs. 1997; 19: 10-14
        • Widmann FK
        Controversies in transfusion medicine: Should a febrile transfusion response occasion the return of the blood component to the blood bank?.
        Pro Transfusion. 1994; 34: 356-358
        • Koneman EW
        • Allen SD
        • Janda WM
        • Schreckenberger PC
        • Winn WC
        Color Atlas and Textbook of Diagnostic Microbiology.
        in: 4th edn. JB Lippincott Company, Philadelphia, PA1992: 95